Daily Insider Signal · July 30, 2026
Insider Alert: Catalyst4, Inc. Bought MLPT Shares (95/100 Signal)
MLPT
Bought
1,000,000
95/100
This filing meets multiple strong signal criteria, scoring 95/100. It is a large open-market purchase by a senior insider with few noise factors, meaning several predefined scoring criteria are satisfied at once. This describes transaction characteristics, not investment merit.
What to watch: Monitor upcoming earnings dates, any subsequent Form 4 amendments, and cluster activity (multiple insiders buying within a 30-day window). Single filings are most informative when corroborated by broader disclosure patterns.
What this signal means
DisclosureSignals scores every SEC Form 4 filing on a 0–100 scale. This trade earned a 95/100 signal score by weighing the transaction type, insider role, trade size, cluster buying, the insider's own history, and whether the trade was discretionary rather than part of a scheduled 10b5-1 plan. A higher score means the transaction meets more of these predefined criteria — it does not indicate investment merit or expected performance. Insiders generally have up to two business days after a transaction to file Form 4, so the transaction date may be earlier than the filing date. Read the full methodology.
See every recent Form 4 filing for MLPT, including historical insider trades and trend context.
Transaction Details
- Insider
- Catalyst4, Inc.
- Company
- MapLight Therapeutics, Inc.
- Transaction Date
- July 30, 2026
- Price Per Share
- $13.00
- Total Value
- $13,000,000
- Type
- Purchase
Get Timely Insider Filing Alerts
DisclosureSignals monitors SEC EDGAR every 15 minutes and scores every Form 4 filing. Alerts are notices about newly available public filings — the underlying transaction may have occurred earlier. Not investment advice.
View Free Dashboard →